Apotransferrin in Patients With β-thalassemia
Clinical trial NCT03993613 · TERMINATED
Trial details
- NCT number
- NCT03993613
- Sponsor
- Prothya Biosolutions
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-21
- Primary completion
- 2022-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.